ProAlt is a biotech company that specializes in creating cutting-edge products for the early detection of colorectal cancer in blood and novel therapeutic antibodies for the treatment of metastatic tumors in the colon, breast, and melanoma. In addition to this, the company provides its own line of recombinant proteins and antibodies, as well as customized services for protein and antibody design and manufacturing (CRO/CMO).

Disease Domain	Count

Neoplasms	5
Endocrinology and Metabolic Disease	1
Nervous System Diseases	1

Top 5 Drug Type	Count

Monoclonal antibody	5

Top 5 Target	Count

CDH5 x ITGA2&ITGB1	1
IL-13Rα2(Interleukin-13 receptor subunit alpha-2)	1
CDH5(Cadherin 5)	1
CDH6(cadherin 6)	1
CDH17 x ITGA2&ITGB1	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 23 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

Preclinical

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

PA-2541 ( CDH5 )	Metastatic breast cancer More	Preclinical
PA-0661 ( CDH5 x ITGA2&ITGB1 )	Metastatic melanoma More	Preclinical
hPA-0661 ( CDH17 x ITGA2&ITGB1 )	Metastatic Colorectal Carcinoma More	Preclinical
CDH6-RGD (Protein Alternatives) ( CDH6 )	Kidney Neoplasms More	Discovery
PA-0554 ( IL-13Rα2 )	Glioblastoma More	Discovery

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis